Skip to product information
1 of 1

FDA ANDA 216935, PREDNISOLONE ACETATE, LUPIN LTD, 08/02/2024

FDA ANDA 216935, PREDNISOLONE ACETATE, LUPIN LTD, 08/02/2024

Regular price $285.64 USD
Regular price Sale price $285.64 USD
Sale Sold out

Contents: Summary Basis of Approval of Bioequivalence Review for PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION 1% application A216935 approved on August 2, 2024 

ANDA: 216935
Company: LUPIN LTD
Drug Name: PREDNISOLONE ACETATE
Active Ingredients: PREDNISOLONE ACETATE
Strength: 1%
Dosage Form/Route: SUSPENSION/DROPS;OPHTHALMIC
Action Date: 08/02/2024
Marketing Status: Prescription
Submission Classification: ORIG-1

71 Pages

View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome